AI in Action E518: Drew Linsley, Co-Founder and CEO at Operant Biopharma

,  | June 24 2024 | JP Valentine

Welcome to episode 518 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Drew Linsley, Co-Founder and CEO at Operant Biopharma. Operant Biopharma’s AI-powered robotic microscope learns to design drugs by watching and controlling diseases over time.  Their platform autonomously designs biological experiments, discovering and optimizing disease treatments. The company focuses on high-need areas like neurodegenerative and kidney diseases, aiming to horizontally address multiple indications and out-license discoveries, blending AI and biology for innovative therapeutic development.

Drew is also an Assistant Professor (Research) in Computational Neuroscience and AI at Brown University. He studies biological and artificial intelligence, and believes we need artificial vision to create intelligent machines capable of reasoning about the world. However, existing artificial vision systems struggle with many visual challenges that we routinely solve in our daily lives. He looks to biological vision to inspire new solutions to these challenges in artificial vision.

In this episode, Drew talks about:

Applying AI to analyze disease data and guide therapeutics autonomously

How Robotic microscopy tracks dynamic biology to aid disease treatment advancements

How AI optimizes drug discovery pipeline & manipulates cellular states for treatment

Applying AI to drive horizontal drug development for diverse indications

Their unique staffing needs within AI, biology and neuroscience

To find out more about all the great work happening within Operant Biopharma, check out the website www.operant.bio. You can also connect with Drew directly on LinkedIn or find out more about his research at sites.brown.edu/drewlinsley.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

Welcome to episode 518 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in North America and Europe.

Today’s guest is Drew Linsley, Co-Founder and CEO at Operant Biopharma. Operant Biopharma’s AI-powered robotic microscope learns to design drugs by watching and controlling diseases over time.  Their platform autonomously designs biological experiments, discovering and optimizing disease treatments. The company focuses on high-need areas like neurodegenerative and kidney diseases, aiming to horizontally address multiple indications and out-license discoveries, blending AI and biology for innovative therapeutic development.

Drew is also an Assistant Professor (Research) in Computational Neuroscience and AI at Brown University. He studies biological and artificial intelligence, and believes we need artificial vision to create intelligent machines capable of reasoning about the world. However, existing artificial vision systems struggle with many visual challenges that we routinely solve in our daily lives. He looks to biological vision to inspire new solutions to these challenges in artificial vision.

In this episode, Drew talks about:

Applying AI to analyze disease data and guide therapeutics autonomously

How Robotic microscopy tracks dynamic biology to aid disease treatment advancements

How AI optimizes drug discovery pipeline & manipulates cellular states for treatment

Applying AI to drive horizontal drug development for diverse indications

Their unique staffing needs within AI, biology and neuroscience

To find out more about all the great work happening within Operant Biopharma, check out the website www.operant.bio. You can also connect with Drew directly on LinkedIn or find out more about his research at sites.brown.edu/drewlinsley.

If you’re interested in exploring our latest Data Science &ML jobs, check out our live vacancies or upload your resume today to keep up to date with all the latest opportunities.

Subscribe to The Alldus Podcast: 

     

related podcasts

ServiceNow Series E167: Doug Rezabek, Director of Strategic Initiatives and ServiceNow Practice at SOFtact Solutions

 Welcome to episode 167 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E520: Brandon Allgood, Chief Data Officer at FogPharma

 Welcome to episode 520 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

ServiceNow Series E166: Holger Brink, Technical Director & Chief ServiceNow Architect at NetImpact Strategies

 Welcome to episode 166 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More